Gene Therapy for Heart Disease Wins Fast-Track Status | P&T … – P&T Community

Posted: February 8, 2017 at 9:40 pm

Gene Therapy for Heart Disease Wins Fast-Track Status | P&T ...
P&T Community
The FDA has granted a fast-track designation for a phase 3 study of Generx (Ad5FGF-4, Angionetics Inc.) cardiovascular angiogenic gene therapy as a one-time ...

and more »

Read the rest here:
Gene Therapy for Heart Disease Wins Fast-Track Status | P&T ... - P&T Community

Related Posts

Comments are closed.

Archives